Related references
Note: Only part of the references are listed.Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII
Daniel J. Rowan et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2013)
Intracisternal enzyme replacement therapy in lysosomal storage diseases: dispersal pathways, regional enzyme concentrations and the effect of posttreatment posture
R. D. Jolly et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2013)
Enzyme Replacement Therapy for Lysosomal Diseases: Lessons from 20 Years of Experience and Remaining Challenges
R. J. Desnick et al.
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 13 (2012)
Biochemical evidence for superior correction of neuronal storage by chemically modified enzyme in murine mucopolysaccharidosis VII
Ha T. Huynh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Identification of N-Glycans Displaying Mannose-6-Phosphate and their Site of Attachment on Therapeutic Enzymes for Lysosomal Storage Disorder Treatment
Jonathan Bones et al.
ANALYTICAL CHEMISTRY (2011)
Expression in CHO Cells and Pharmacokinetics and Brain Uptake in the Rhesus Monkey of an IgG-Iduronate-2-Sulfatase Fusion Protein
Jeff Zhiqiang Lu et al.
BIOTECHNOLOGY AND BIOENGINEERING (2011)
Age-related lysosomal dysfunction: an unrecognized roadblock for cobalamin trafficking?
Hua Zhao et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
NSAID Acyl Glucuronides and Enteropathy
Urs A. Boelsterli et al.
CURRENT DRUG METABOLISM (2011)
Enzyme replacement therapy for lysosomal storage diseases
Robin H. Lachmann
CURRENT OPINION IN PEDIATRICS (2011)
Kinetic Analysis of β-Galactosidase and β-Glucuronidase Tetramerization Coupled with Protein Translation
Tomoaki Matsuura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2011)
Diagnosis of the mucopolysaccharidoses
Thomas J. A. Lehman et al.
RHEUMATOLOGY (2011)
Structural basis for recognition of phosphodiester-containing lysosomal enzymes by the cation-independent mannose 6-phosphate receptor
Linda J. Olson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
Bret D. Wallace et al.
SCIENCE (2010)
Topological aspects of oligomeric UDP-glucuronosyltransferases in endoplasmic reticulum membranes: Advances and open questions
Karl Walter Bock et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Mutations and Polymorphisms in GUSB Gene in Mucopolysaccharidosis VII (Sly Syndrome)
Shunji Tomatsu et al.
HUMAN MUTATION (2009)
Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function
Paul Saftig et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Acidic amino acid tag enhances response to enzyme replacement in mucopolysaccharidosis type VII mice
Adriana M. Montano et al.
MOLECULAR GENETICS AND METABOLISM (2008)
Chemically modified β-glucuronidase crosses blood-brain barrier and clears neuronal storage in murine mucopolysacchariclosis VII
Jeffrey H. Grubb et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Improvements in mucopolysaccharidosis I mice after adult retroviral vector-mediated gene therapy with immunomodulation
Xiucui Ma et al.
MOLECULAR THERAPY (2007)
Clinical response to persistent, low-level β-glucuronidase expression in the murine model of mucopolysaccharidosis type VII
A. Donsante et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2007)
Gene therapy for mucopolysaccharidosis
Katherine P. Ponder et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Gene targeting in vivo by adeno-associated virus vectors
Daniel G. Miller et al.
NATURE BIOTECHNOLOGY (2006)
Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain
CN Cearley et al.
MOLECULAR THERAPY (2006)
Viral gene therapy strategies: from basic science to clinical application
LS Young et al.
JOURNAL OF PATHOLOGY (2006)
Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII
C Vogler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Early onset of lysosomal storage disease in a murine model of mucopolysaccharidosis type VII: Undegraded substrate accumulates in many tissues in the fetus and very young MPS VII mouse
C Vogler et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2005)
Gene therapy for lysosomal storage diseases: the lessons and promise of animal models
NM Ellinwood et al.
JOURNAL OF GENE MEDICINE (2004)
Role of the mammalian retromer in sorting of the cation-independent mannose 6-phosphate receptor
CN Arighi et al.
JOURNAL OF CELL BIOLOGY (2004)
Rapid evolution of β-glucuronidase specificity by saturation mutagenesis of an active site loop
ML Geddie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Involvement of AP-2 binding sites in regulation of human beta-glucuronidase
C Kunert-Keil et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2004)
Simultaneous cell death and desquamation of the embryonic diffusion barrier during epidermal development
M Saathoff et al.
EXPERIMENTAL CELL RESEARCH (2004)
Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients
U Matte et al.
MOLECULAR GENETICS AND METABOLISM (2003)
Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors
AI Brooks et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Hydrolysis of 4-methylumbelliferyl-β-D-glucuronide in differing sample fractions of river waters and its implication for the detection of fecal pollution
AH Farnleitner et al.
WATER RESEARCH (2002)
Biodistribution, kinetics, and efficacy of highly phosphorylated and non-phosphorylated β-glucuronidase in the murine model of mucopolysaccharidosis VII
MS Sands et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A novel inhibitor of β-glucuronidase:: L-aspartic acid
BL Kreamer et al.
PEDIATRIC RESEARCH (2001)
Expression of bacterial β-glucuronidase in human bile:: an in vitro study
JW Leung et al.
GASTROINTESTINAL ENDOSCOPY (2001)
Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer
TM Daly et al.
GENE THERAPY (2001)
Primary adult human astrocytes as an ex vivo vehicle for β-glucuronidase delivery in the brain
C Serguera et al.
MOLECULAR THERAPY (2001)
Regulation of human β-glucoronidase by A23187 and thapsigargin in the hepatoma cell line HepG2
B Sperker et al.
MOLECULAR PHARMACOLOGY (2001)
In vitro evolution of beta-glucuronidase into a beta-galactosidase proceeds through non-specific intermediates
I Matsumura et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Treatment of a lysosomal storage disease, mucopolysaccharidosis VII, with microencapsulated recombinant cells
CJD Ross et al.
HUMAN GENE THERAPY (2000)
Expression and function of β-glucuronidase in pancreatic cancer:: potential role in drug targeting
B Sperker et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2000)
Significantly increased expression of β-glucuronidase in the central nervous system of mucopolysaccharidosis type VII mice from the latency-associated transcript promoter in a nonpathogenic herpes simplex virus type 1 vector
J Zhu et al.
MOLECULAR THERAPY (2000)
Secreted human β-glucuronidase:: a novel tool for gene-directed enzyme prodrug therapy
D Weyel et al.
GENE THERAPY (2000)
Share Paper
